发明名称 | Agent for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory T cells | ||
摘要 | The present invention relates to an agent for the treatment and/or prophylaxis of an autoimmune disease, an agent for the formation of regulatory T cells (TReg) in an organism and various methods in which the agents according to the invention are used. | ||
申请公布号 | US9616105(B2) | 申请公布日期 | 2017.04.11 |
申请号 | US201514752726 | 申请日期 | 2015.06.26 |
申请人 | AiCuris GmbH & Co. KG | 发明人 | Paulsen Daniela;Brunner Nina;Bray Dorothy |
分类号 | A61K38/00;C07K14/47;A61K38/16;A61K38/20;A61K35/17;A61K45/06 | 主分类号 | A61K38/00 |
代理机构 | Morrison & Foerster LLP | 代理人 | Morrison & Foerster LLP |
主权项 | 1. A method for the treatment and/or prevention of the worsening of an autoimmune disease in an organism, the method comprising: (a) administering a mutein of human interleukin-2 (hIL-2 mutein) to the organism, wherein said hIL-2 mutein has an amino acid substitution in at least one of the positions 20, 88 or 126, numbered in accordance with the hIL-2 wild type sequence as set forth in SEQ ID NO: 1; and (b) if necessary, repeating step (a), wherein the autoimmune disease is type I diabetes, multiple sclerosis, or systemic lupus erythematosus, and wherein the administration induces regulatory T cells in the organism. | ||
地址 | Wuppertal DE |